U.S. By

Roundup Settlement Approved: What the $7.25 Billion Bayer Deal Means for Claimants

A Missouri judge on Friday approved Bayer’s $7.25 billion settlement of lawsuits claiming that its Roundup weedkiller causes cancer, the Guardian and BBC News reported. The ruling could end litigation that has weighed on the German company for close to a decade. Bayer denies that Roundup causes cancer.

What did the judge decide?

Judge Timothy Boyer of a state court in St. Louis found the settlement fair, reasonable and adequate. He overruled objections from some lawyers and claimants who argued that payouts to individual cancer victims would be too low, partly because people who settled earlier received more.

The judge also said that delaying payments could force victims, including some with terminal cancer, to wait an indeterminate number of years, according to the Guardian.

Who gets paid, and how much?

BBC News reported that the nationwide settlement covers Roundup users who already have non-Hodgkin lymphoma and those who develop it in the future. Payments to participants range from $10,000 to $165,000. The amount depends on how often a person used the product, when they were diagnosed and how severe the illness is.

Bayer will pay into a fund annually for up to 21 years, for as much as $7.25 billion in total. The Guardian reported that the deal aims to resolve nearly all current and future Roundup claims in the U.S., which it said numbered approximately 65,000 in state and federal courts.

Does this end every Roundup case?

Not entirely. The settlement excludes some lawsuits still pending in federal court. Bayer has said about 200 of those cases are still being litigated and that a Supreme Court decision gives it strong defenses.

How did the Supreme Court decision change the picture?

Five months before the approval, in June, the Supreme Court overturned a $1.25 million jury award to a Missouri man, John Durnell, who blamed years of exposure to glyphosate, Roundup’s active ingredient, for his non-Hodgkin lymphoma. By a 7-2 vote, the court agreed with Bayer that a federal pesticide law bars failure-to-warn claims brought under state law. That undercut a central pillar of many lawsuits.

Christopher Seeger, a lawyer for many of the plaintiffs, said the ruling narrowed Roundup victims’ ability to pursue claims in court. After the approval, he said his side looks forward to getting relief to victims as quickly as possible.

What does this mean for Bayer?

Bayer’s chief executive, Bill Anderson, called the approval a decisive milestone in the company’s strategy to reduce the risks of pending and future Roundup litigation. The Guardian said Bayer’s share price has fallen 46% since it bought Monsanto, which makes the weedkiller, for $63 billion in 2018. The company settled much of the litigation for $10.9 billion in 2020 but could not win court approval of a $1.25 billion settlement covering future claims.

Why does the health question remain contested?

Bayer says decades of studies show glyphosate does not cause cancer. BBC News reported that the International Agency for Research on Cancer, part of the World Health Organization, identified glyphosate in 2015 as a probable human carcinogen. Bayer and some other regulators, including the U.S. Environmental Protection Agency, dispute that finding.

Around Prague, based on reporting by The Guardian, BBC News

Share: Telegram WhatsApp

More U.S. news

Greenwich Rx Recall: Compounded Sterile Products Pulled Nationwide
Greenwich Rx, a 503A compounding pharmacy in Tomball, Texas, is voluntarily recalling specific lots of compounded sterile products across the United States because of a potential lack of sterility ass
What the Penny Law Means for Your Cash Purchases: Prices Round to the Nickel
President Donald Trump on Friday signed the Common Cents Act, a bipartisan law that formally ends production of the penny. For shoppers who pay in cash, the biggest change is rounding: the law sets a
Xentrawave Adult Portable Bed Rails Recall: Entrapment Hazard, One Death Reported
The U.S. Consumer Product Safety Commission (CPSC) announced a recall on Nov. 19 of about 2,114 Xentrawave adult portable bed rails sold in the United States. The agency says the products violate the
White House Replaces Cyber Director Sean Cairncross After a Run of Tech Outages
The White House has replaced National Cyber Director Sean Cairncross, the administration’s top cybersecurity adviser, after a week of technology outages that disrupted banking, air traffic control and
CrowdStrike and Zscaler Takeover Talks: What the Reports Say
CrowdStrike is in discussions to acquire fellow cybersecurity company Zscaler, according to a Bloomberg report relayed by BigGo Finance. Zscaler shares jumped as much as 18% in extended trading Friday
Cipton Bike Helmet Recall: 16,730 Youth Helmets Fail Safety Standard
Cipton is recalling 16,730 bicycle helmets in the United States because they violate the mandatory federal safety standard for bicycle helmets, according to a notice from the U.S. Consumer Product Saf

Related news

Greenwich Rx, a 503A compounding pharmacy in Tomball, Texas, is voluntarily recalling specific lots of compounded sterile products across the United States because of a potential lack of sterility assurance, according to a company announcem
President Donald Trump on Friday signed the Common Cents Act, a bipartisan law that formally ends production of the penny. For shoppers who pay in cash, the biggest change is rounding: the law sets a procedure for stores and other businesse
The U.S. Consumer Product Safety Commission (CPSC) announced a recall on Nov. 19 of about 2,114 Xentrawave adult portable bed rails sold in the United States. The agency says the products violate the mandatory standard for adult portable be
The White House has replaced National Cyber Director Sean Cairncross, the administration’s top cybersecurity adviser, after a week of technology outages that disrupted banking, air traffic control and other sectors. Kirsten Davies, the Pent
CrowdStrike is in discussions to acquire fellow cybersecurity company Zscaler, according to a Bloomberg report relayed by BigGo Finance. Zscaler shares jumped as much as 18% in extended trading Friday, while CrowdStrike shares fell more tha
Cipton is recalling 16,730 bicycle helmets in the United States because they violate the mandatory federal safety standard for bicycle helmets, according to a notice from the U.S. Consumer Product Safety Commission (CPSC) dated Nov. 19, 202
Nvidia’s stock is down again on Friday, putting the chipmaker on course for a seventh straight weekly loss, its longest such run since 2008. The main causes, according to BigGo Finance, Quartz and Superpower Daily, are worries about how lon
U.S. stocks fell sharply on Friday, Nov. 20, 2026, as the AI-driven selloff deepened. The Nasdaq Composite lost 1,261.47 points, or 5.28%, to close at 22,617.73. The S&P 500 fell 3.70% to 6,910.39, and the Dow Jones Industrial Average dropp
House Speaker Mike Johnson sent a letter to his Republican colleagues on Friday telling them to show up for work during the final weeks of the party's majority. He wrote that Republicans had to postpone a planned floor rule this week becaus
President Donald Trump said Friday that the United States will not allow American companies to build artificial intelligence data centers in other countries and will hit any that try with “tremendous penalties.” He gave no details, and sour
Broadcom stock is down about 12% on Friday, Nov. 20, 2026, as a sell-off in AI chip stocks widens. Shares traded at $306.60 at 1:30 p.m. ET, down 11.55% from Thursday's close of $346.65, with a day range of $304.65 to $342.90.The broader ma
AMD stock is down about 11% on Friday, Nov. 20, 2026, as investors react to a short seller's report on the chipmaker's business ties in China. Shares traded at $434.15 at 1:10 p.m. ET, down 11.25% from Thursday's close of $489.19. They have